We report 3 cases of congenital multiple glomus tumors seen during the last 5 years. One of them showed autosomal dominant inheritance with male-to-male transmission. The remaining patients had no family history of similar lesions. The clinical and histopathological aspects of our patients support the recently described type 2 segmental manifestation of multiple glomus tumors. One of the cases showed associated multiple and giant trichilemmal cysts with a linear distribution in the scalp.

1.
Gorlin RJ, Fusaro RM, Benton JW: Multiple glomus tumor of the pseudocavernous hemangioma type: Report of a case manifestating a dominant inheritance pattern. Arch Dermatol 1960;82:776–778.
2.
Sybert VP: Genetic Skin Disorders. New York, Oxford University Press, 1997, pp 380–383.
3.
Happle R, König A: Type 2 segmental manifestation of multiple glomus tumors: A review and reclassification of 5 case reports. Dermatology 1999;198:270–272.
4.
Moss C, Savin J: Dermatology and the New Genetics. London, Blackwell Science, 1995, pp 1–35.
5.
Happle R: Segmental forms of autosomal dominant skin disorders: Different types of severity reflect different states of zygosity (letter). Am J Med Genet 1996;66:241–242.
6.
McEvoy BF, Waldman PM, Tye MJ: Multiple hamartomatous glomus tumors of the skin. Arch Dermatol 1971;104:188–191.
7.
Conant MA, Wiesenfeld SL: Multiple glomus tumors of the skin. Arch Dermatol 1971;103: 481–485.
8.
Leppard BJ, Sanderson KV: The natural history of trichilemmal cysts. Br J Dermatol 1976;94: 379–390.
9.
Kirkham N: Tumors and cysts of the epidermis; in Elder D (ed): Lever’s Histopathology of the Skin. Philadelphia, Lippincott-Raven, 1997, pp 685–745.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.